Research

Q & A: Dr. Martin Voss, 2012 KCA Grant Recipient thumbnail image

Q & A: Dr. Martin Voss, 2012 KCA Grant Recipient

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research. Dr. Martin Voss is a medical oncologist and the Clinical Director of Genitourinary Medical Oncology Service at Memorial Sloan Kettering Cancer Center. He received a 2012 ASCO Young Investigator Award supported by the KCA. We spoke…

Q&A: Dr. Abraham Hakimi, 2014 KCA Grant Recipient thumbnail image

Q&A: Dr. Abraham Hakimi, 2014 KCA Grant Recipient

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research. Dr. Abraham Hakimi is a urologist and researcher at Memorial Sloan Kettering Cancer Center in New York where he co-leads the Translational Kidney Cancer Program with Dr. Robert Motzer. Dr. Hakimi received the 2014 Andrew C.…

Q & A: Dr. Elizabeth Jaffee, 1995 KCA Grant Recipient

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research. Dr. Elizabeth Jaffee received the first-ever KCA research grant in 1995 - the Eugene P. Schonfeld Award (now the Young Investigator Award), named for the KCA's founder. Her project examined whether the immune system could recognize…

Q & A: Dr. Brandon Manley, 2020 YIA recipient thumbnail image

Q & A: Dr. Brandon Manley, 2020 YIA recipient

Dr. Brandon Manley is a urologic oncologist at the Moffitt Cancer Center in Tampa, Florida. He received a 2020 Young Investigator Award for an “Investigation of the Aberrant Epidermal Growth Factor Receptor Splicing Proteome to Determine Drug Repurposing Strategies for ccRCC”, which examines how EGFR, an effective drug target in various cancers, could be useful in kidney cancer.We spoke with…

Q & A: Dr. Chiara Di Malta, 2020 YIA Recipient thumbnail image

Q & A: Dr. Chiara Di Malta, 2020 YIA Recipient

Dr. Chiara Di Malta is a postdoctoral fellow at the Telethon Institute of Genetics and Medicine in Pozzuoli, Italy. She received a 2020 Young Investigator Award for her project, called “Exploiting the potential of MiT/TFE factors inhibition to treat inherited kidney cancers”, which focuses on two types of genetic renal cell carcinomas. We spoke to Dr. Di Malta about…

Q & A: Dr. Ritesh Kotecha, 2020 YIA Recipient thumbnail image

Q & A: Dr. Ritesh Kotecha, 2020 YIA Recipient

Dr. Ritesh Kotecha is a medical oncologist at Memorial Sloan Kettering Cancer Center in New York. He received a 2020 Young Investigator Award for his project “HLA Evolutionary Diversity - A Population Specific Biomarker for Kidney Cancer Immunotherapy”, which will examine inherited cell membrane proteins as potential biomarkers for personalized kidney cancer immunotherapy. We spoke to Dr. Kotecha about his…

Q & A: Dr. Frank Mason, 2020 YIA recipient thumbnail image

Q & A: Dr. Frank Mason, 2020 YIA recipient

Dr. Frank Mason is a cell biologist and research assistant professor at the Vanderbilt University Medical Center in Nashville, Tennessee. He received a 2020 Young Investigator Award for his investigation of the “Therapeutic vulnerability of SETD2 mutant RCC.”We spoke with Dr. Mason about his work and what it may mean for patients. Can you describe your project? Dr. Mason: What…

Q &A: Dr. Heather Christofk and Dr. Brian Shuch thumbnail image

Q &A: Dr. Heather Christofk and Dr. Brian Shuch

Dr. Heather Christofk and Dr. Brian Shuch of the University of California, Los Angeles received a 2020 Advanced Discovery Award for their investigation of “Intracellular asparagine regulates mTORC1 activity and cancer cell proliferation”, which takes a closer look at how the amino acid asparagine might be important in kidney cancer growth. Dr. Christofk is a Professor of Biological Chemistry, and…

Q & A: Dr. Haifeng Yang and Dr. William Kim thumbnail image

Q & A: Dr. Haifeng Yang and Dr. William Kim

Dr. Haifeng Yang and Dr. William Kim received a 2020 Advanced Discovery Award for their project to “Investigating the anti-tumor efficacy of a STING agonist on PBRM1-deficient ccRCC tumors,” which will examine whether a novel compound can help in kidney cancer treatment. Both Yang and Kim trained with Dr. William Kaelin, Jr. at the Dana Farber Cancer Institute as postdoctoral…

Nobel-winning CRISPR technology is already demystifying cancer thumbnail image

Nobel-winning CRISPR technology is already demystifying cancer

Dr. Emmanuelle Charpentier and Dr. Jennifer Doudna. The 2020 Nobel Prize in Chemistry was awarded last week to two researchers for developing a technique – akin to “genetic scissors” – that lets scientists precisely snip pieces of DNA wherever they want to. Dr. Emmanuelle Charpentier of the Max Planck Unit for the Science of Pathogens in Berlin, Germany and Dr.…

« Previous 1 … 11 12 13 14 15 16 Next »